Renaissance Investment Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Buy
8,037
+204
+3% +$23.9K 0.2% 45
2026
Q1
$942K Sell
7,833
-555
-7% -$64.1K 0.2% 46
2025
Q4
$883K Buy
8,388
+90
+1% +$8.45K 0.18% 51
2025
Q3
$696K Sell
8,298
-99
-1% -$8.15K 0.14% 54
2025
Q2
$665K Sell
8,397
-250
-3% -$19.9K 0.14% 53
2025
Q1
$776K Sell
8,647
-1,108
-11% -$103K 0.19% 53
2024
Q4
$970K Sell
9,755
-140
-1% -$14.4K 0.2% 50
2024
Q3
$1.12M Sell
9,895
-872
-8% -$104K 0.23% 53
2024
Q2
$1.36M Sell
10,767
-920
-8% -$119K 0.3% 48
2024
Q1
$1.54M Sell
11,687
-437
-4% -$53.9K 0.35% 49
2023
Q4
$1.32M Buy
12,124
+790
+7% +$82K 0.33% 48
2023
Q3
$1.17M Hold
11,334
0.33% 48
2023
Q2
$1.31M Sell
11,334
-614
-5% -$69.7K 0.34% 49
2023
Q1
$1.27M Hold
11,948
0.36% 49
2022
Q4
$1.33M Sell
11,948
-22
-0.2% -$2.25K 0.4% 48
2022
Q3
$1.17M Buy
11,970
+2,018
+20% +$180K 0.36% 48
2022
Q2
$907K Buy
9,952
+3
+0% +$266 0.3% 47
2022
Q1
$872K Sell
9,949
-1,579
-14% -$124K 0.26% 49
2021
Q4
$884K Sell
11,528
-2,782
-19% -$222K 0.21% 51
2021
Q3
$1.07M Sell
14,310
-2,489
-15% -$189K 0.27% 46
2021
Q2
$1.31M Sell
16,799
-2,853
-15% -$212K 0.33% 46
2021
Q1
$1.45M Sell
19,652
-63,526
-76% -$4.69M 0.4% 47
2020
Q4
$6.49M Buy
83,178
+1,067
+1% +$81.6K 1.91% 22
2020
Q3
$6.5M Sell
82,111
-5
-0% -$392 2.16% 19
2020
Q2
$6.06M Sell
82,116
-2,701
-3% -$203K 2.23% 19
2020
Q1
$6.23M Buy
84,817
+1,051
+1% +$82.6K 2.94% 13
2019
Q4
$7.27M Sell
83,766
-1,581
-2% -$130K 2.59% 14
2019
Q3
$6.86M Sell
85,347
-334
-0.4% -$26.8K 2.65% 12
2019
Q2
$6.86M Buy
85,681
+2,506
+3% +$192K 2.56% 12
2019
Q1
$6.6M Buy
83,175
+641
+0.8% +$47.9K 2.69% 14
2018
Q4
$6.02M Buy
82,534
+327
+0.4% +$23.1K 2.88% 14
2018
Q3
$5.57M Sell
82,207
-548
-0.7% -$34.9K 2.14% 18
2018
Q2
$4.79M Buy
82,755
+76
+0.1% +$4.29K 1.93% 21
2018
Q1
$4.3M Sell
82,679
-5,623
-6% -$304K 1.74% 28
2017
Q4
$4.74M Sell
88,302
-1,225
-1% -$67.9K 1.89% 26
2017
Q3
$5.47M Buy
89,527
+186
+0.2% +$11.3K 2.29% 19
2017
Q2
$5.46M Sell
89,341
-1,153
-1% -$70.2K 2.4% 18
2017
Q1
$5.49M Buy
90,494
+130
+0.1% +$7.89K 2.43% 16
2016
Q4
$5.08M Sell
90,364
-198
-0.2% -$11.6K 2.39% 16
2016
Q3
$5.39M Buy
90,562
+762
+0.8% +$44.6K 2.59% 10
2016
Q2
$4.94M Sell
89,800
-251
-0.3% -$13.4K 2.45% 14
2016
Q1
$4.55M Buy
90,051
+98
+0.1% +$4.8K 2.29% 17
2015
Q4
$4.53M Buy
89,953
+4,650
+5% +$234K 2.21% 20
2015
Q3
$4.02M Sell
85,303
-2,527
-3% -$134K 2.09% 23
2015
Q2
$4.77M Buy
87,830
+488
+0.6% +$27.4K 2.23% 17
2015
Q1
$4.79M Buy
87,342
+2,486
+3% +$141K 2.21% 19
2014
Q4
$4.6M Buy
84,856
+3,052
+4% +$170K 2.17% 20
2014
Q3
$4.63M Buy
81,804
+1,596
+2% +$89.6K 2.23% 16
2014
Q2
$4.43M Buy
80,208
+1,304
+2% +$71.1K 2.15% 16
2014
Q1
$4.27M Buy
78,904
+3,105
+4% +$161K 2.17% 16
2013
Q4
$3.62M Buy
75,799
+1,063
+1% +$48.6K 1.84% 22
2013
Q3
$3.4M Buy
74,736
+1,624
+2% +$74.1K 1.88% 23
2013
Q2
$3.24M Buy
+73,112
New +$3.27M 1.84% 22

Other funds holding MRK

Renaissance Investment Group's MRK Position: Q2 2026 in Review

Renaissance Investment Group increased its Merck (MRK) stake by 2.6% in Q2 2026, buying an estimated $23.9K and bringing the position to 8,037 shares worth $1.03M. The position accounts for 0.2% of the portfolio, ranked #45.

Renaissance Investment Group first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $7.27M in Q4 2019. 1,038 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Renaissance Investment Group held 8,037 shares of Merck worth $1.03M as of Q2 2026.
  • Renaissance Investment Group bought 204 Merck shares in Q2 2026, an estimated $23.9K.
  • Merck made up 0.2% of Renaissance Investment Group's portfolio in Q2 2026, its #45 holding.
  • Renaissance Investment Group first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Renaissance Investment Group's Merck position peaked at $7.27M in Q4 2019.
  • 1,038 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Renaissance Investment Group's 13F filing for Q2 2026, filed 8 Jul 2026.